CHRONIC WOUNDS - MICROBIOLOGY AND BIOFILM FORMATION
Keywords:
chronic wounds, microbial agents, biofilm, microbial swab, TCPAbstract
Introduction: Chronic wounds are wounds that do not heal for more than 4 weeks. Among the most important causes of wound chronicity are wound infection, biofilm formation with microbial agents that are resistant to antimicrobial agents.
Aim: To investigate microbial agents in chronic wounds, their potential to form biofilm.
Material and methods: This was a prospective study involving 24 patients from the University Clinic for in Skopje. Microbiological swabs were taken from patients with chronic wounds on the lower extremities, and were analyzed at the Institute of Microbiology and Parasitology, Faculty of Medicine in Skopje. The biofilm formation potential in isolates was determined using the tissue culture plate (TCP) biofilm detection method.
Results: In 17 patients, at least one microorganism was isolated from 23 wounds, a total of 36, and in 7 patients there was no positive isolate from 7 wounds. Eighteen wounds (60%) had an isolate with the potential to form a biofilm. The following microorganisms from the wound samples were recorded: 17 (47%) isolates of the genus Staphylococcus, 4 (11%) isolates each from the genera Proteus and Pseudomonas, 3 (8%) isolates each from Enterococcus and Escherichia, 2 (6%) isolates from Streptococcus, 1 (3%) each isolate from the genera Acinetobacter, Enterobacter and Candida albicans.
Conclusion: In 60% of the isolates, a biofilm formation with different degrees was confirmed. A statistically significant association was found between the degree of wound healing and isolates with low potential for biofilm formation, as well as the type of isolate.
References
Werdin F, Tennenhaus M, Schaller HE, Rennekampff HO. Evidence-based management strategies for treatment of chronic wounds. Eplasty 2009; 9: e19. PMID: 19578487.
Abdulah AM, Abdulah NDH. Ministry of Health Malaysia: Wound care manual. 1th ed; 2014. Available from: https://www.slideshare.net/slideshow/wound-care-manual-1st-edition-2014/76550541
Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008; 453(7193): 314-321. doi: 10.1038/nature07039.
Attinger C, Wolcott R. Clinically Addressing Biofilm in Chronic Wounds. Adv Wound Care 2012; 1(3): 127-132. doi: 10.1089/wound.2011.0333.
MacLeod AS, Mansbridge JN. The Innate Immune System in Acute and Chronic Wounds. Adv Wound Care 2016; 5(2): 65-78. doi: 10.1089/wound.2014.0608.
Hurlow J, Couch K, Laforet K, Bolton L, Metcalf D, Bowler P. Clinical Biofilms: a challenging frontier in wound care. Adv Wound Care (New Rochelle) 2015; 4(5): 295-301. doi: 10.1089/wound.2014.0567.
Sangwan S, Pratibha P, Hemender T. Anti-biofilm enzymes: a strategy to remove biofilms. Agrobios 2019; 17(12): 35-75.
Grant SS, Hung DT. Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence 2013; 4(4): 273-283. doi: 10.4161/viru.23987.
Bowler P. Antibiotic resistance and biofilm tolerance: A combined threat in the treatment of chronic infections. Journal of wound care 2018; 27(5): 273-277. doi: 10.12968/jowc.2018.27.5.273.
Davies DG, Marques CNH. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol 2009; 191(5): 1393-1403. doi: 10.1128/jb.01214-08.
Leid JG, Wilson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN- gamma-mediated macrophage killing. J Immunol 2005; 175(11): 7512-7518. doi: 10.4049/jimmunol.175.11.7512.
Goldberg SR, Diegelmann RF. What makes wounds chronic. SurgialClinics of North America 2020; 100(4): 681-693. doi.org/10.1016/j.suc.2020.05.001.
Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classeson emerging resistance. Clinical Microbiology and infection 2005; 11(5): 4-16. doi: 10.1111/j.1469-0691.2005.01238.x.
James GA, Swogger E, Wolcott R, Pulcini EDL, Secor P, Sestrich J, et al. Biofilms and chronic wounds.Wound Repair and Regeneration 2008; 16(1): 37-44. doi: 10.1111/j.1524-475X.2007.00321.x.
Breskovska H, Gjorgjeska A, Peneva M, Dzokic Gj, Nikolovska S, Duma S, et al. Efektot na hiperbarnata oksigeno terapija kako adjuvantna terapija vo zazdravuvanjeto na hronicnite rani. Medicus 24(3). 2019; 270-275.
Eriksson E, Liu PY, Schultz GS, Martins-Green MM, Tanaka R, Weir D, et al. Chronic wounds: Treatment consensus. Wound Rep Reg 2022; 30(2): 156-171. doi: 10.1111/wrr.12994.
Manual of Clinical Microbiology,7th ed. American Society of Microbiology, Washington, D.C,1999.
Christensen GD, Simpson WA, Bismo AL, Beachery EH. The adherence of the slime- producing strains of Staphylococcus epidermidis to smooth surfaces. Infect immune 1982; 37(1): 318-326. doi: 10.1128/iai.37.1.318-326.1982.
Stepanovic S, Vukovic D, Hola V, Bonaventura G, Djukic S, Irkovic IC, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practicalecommendations for assessment of biofilm production by staphylococci. APMIS 2007; 71(5): 687-690. doi: 10.1111/j.1600-0463.2007.apm_630.x.
Wu YK, Cheng NC, Cheng CM. Biofilms in chronic wounds: pathogenesis and diagnosis. Trends Biotechnol 2019; 37(5): 505‐517. doi: 10.1016/j.tibtech.2018.10.011.
Basu S, Ramchuran Panray T, Bali Singh T, Gulati AK, Shukla VK. A prospective, descriptive study to identify the microbiological profile of chronic wounds in outpatients. Ostomy Wound Manage 2009; 55(1): 14-20. PMID: 19174585.
Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14(2): 244–269. doi: 10.1128/CMR.14.2.244-269.2001.
Kalan L, Loesche M, Hodkinson BP, Heilmann K, Ruthel G, Gardner SE, et al. Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. MBio 2016; 7(5): e01058-e1116. doi: 10.1128/mBio.01058-16.
Kalan L, Grice EA. Fungi in the wound microbiome. Adv Wound Care 2018; 7(7): 247-255. doi: 10.1089/wound.2017.0756.
Rahim K, Saleha S, Zhu X, Huo L, Basit A, Franco OL. Bacterial contribution in chronicity of wounds. Microb Ecol 2017; 73(3): 710-721. doi: 10.1007/s00248-016-0867-9.
Allison DL, Willems HME, Jayatilake JAMS, Bruno VM, Peters BM, Shirtliff ME. Candida-Bacteria Interactions: Their Impact on Human Disease. Microbiol Spectr 2016; 4(3): 103-136. doi: 10.1128/microbiolspec.VMBF-0030-2016.
Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 2013; 62(3): 923-930. doi: 10.2337/db12-0771.
Lavigne JP, Sotto A, Dunyach-Remy C, Lipsky BA. New molecular techniques to study the skin microbiota of diabetic foot ulcers. Adv Wound Care (New Rochelle) 2015; 4(1): 38-49. doi: 10.1089/wound.2014.0532.
